Scottsdale, Arizona--(Newsfile Corp. - February 7, 2024) - PathogenDx, a leader in next-generation microarray technology for better health and safety, announced the launch of D 3 Array™-UTI, a ...
Scottsdale, AZ, February 20, 2025 --(PR.com)-- D3 Array™ technological assays address the gaps that Real-time PCR and Next-Generation Sequencing cannot solve in agriculture, food safety, environmental ...
PathogenDx's Microarray Detection Platform is the fastest and most cost-effective test for UTI detection with higher throughput for efficient and accurate diagnosis. Neeraj Jadhav, Industry Analyst at ...
Medical and consumer genetics innovator Genefluence today announces the first use of its rapid, near-patient diagnostic platform to screen for urinary tract infections (UTIs), at the Royal Hospital ...
A new and alarming fungal pathogen, Candida auris (C. auris), is catalyzing a global crisis across long-term care facilities. The Centers for Disease Control and Prevention (CDC) announced C. auris to ...
An analysis of Medicare claims data found a 60-fold increase in the use of unregulated rapid molecular diagnostic tests for urinary tract infections (UTIs) in older adults from 2016 to 2023, ...
Tech Times on MSN
UK care home gets first lab-free PCR test that reads UTI resistance genes in 60 minutes
Rapid UTI PCR testing entered UK clinical use for the first time at the Royal Hospital Chelsea on October 28, 2026.
A recent McKnight’s article on a new consensus statement recommending against PCR urine testing in long-term care raises valid concerns about inappropriate use, particularly when results are ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results